DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $423,507 | +69.7% | 1,707 | +64.1% | 0.05% | +76.7% |
| Q2 2023 | $249,627 | -11.4% | 1,040 | -7.0% | 0.03% | -11.8% |
| Q1 2023 | $281,781 | +3030.9% | 1,118 | +3094.3% | 0.03% | +3300.0% |
| Q2 2021 | $9,000 | -93.0% | 35 | -96.1% | 0.00% | -94.7% |
| Q2 2019 | $129,000 | +8.4% | 900 | 0.0% | 0.02% | +5.6% |
| Q1 2019 | $119,000 | +28.0% | 900 | 0.0% | 0.02% | +12.5% |
| Q4 2018 | $93,000 | -5.1% | 900 | 0.0% | 0.02% | +14.3% |
| Q3 2018 | $98,000 | +10.1% | 900 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $89,000 | +1.1% | 900 | 0.0% | 0.01% | -6.7% |
| Q1 2018 | $88,000 | -5.4% | 900 | -10.0% | 0.02% | 0.0% |
| Q4 2017 | $93,000 | -65.6% | 1,000 | -72.2% | 0.02% | -81.0% |
| Q1 2014 | $270,000 | -2.9% | 3,603 | +0.0% | 0.08% | -3.7% |
| Q4 2013 | $278,000 | +11.2% | 3,602 | 0.0% | 0.08% | 0.0% |
| Q3 2013 | $250,000 | +3.7% | 3,602 | -5.2% | 0.08% | -1.2% |
| Q2 2013 | $241,000 | – | 3,801 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |